Most Read News

Gland Pharma also established that its version is bioequivalent and therapeutically equivalent to the reference listed drug.

Last week, the company secured another contract worth ₹140 Crore for making multi-purpose wagons.

Harris added that in FY26, the company’s performance will depend on macroeconomic factors and the extent of clarity achieved.

This new centre will house a skilled and scalable engineering team that will work hand-in-hand with Tennant on designing new products, managing the product life cycle, and strengthening core business functions.

Wipro also stated that it will provide Gen-AI powered products to restructure self-service, resulting in better user experiences.

Top gainers in the Indian Benchmark Index Sensex include Eternal, Bharti Airtel, Tech Mahindra, IndusInd Bank

The NFO is available for subscription from June 02 to June 16, 2025.

The Day-Ahead Contingency and Term-Ahead Market (TAM), posted a volume of 1,684 MU, higher by 38% against 1,221 MU in May 2024.

The quarterly EBITDA of the company has reached ₹1,791 crore, with a 12.5% year-on-year growth due to stable operating activities and maintained cost efficiency.

Defence stocks witnessed a rally despite a dim market sentiment, adding over 1% in Nifty India Defence index. This marks a third straight session of gains.